FDA 批准了新的肾脏手术，通过破坏过度活跃的神经来降低血压。 FDA approves new kidney procedure to lower blood pressure by disrupting overactive nerves.

一种名为肾衰减的新疗法为高血压患者带来了希望,尽管有多种药物治疗,但高血压患者仍不受控制。 A new treatment called renal denervation offers hope for patients with high blood pressure that remains uncontrolled despite multiple medications. 这种微创手术经 FDA 批准，包括将导管穿入肾脏并使用能量来破坏过度活跃的神经。 Approved by the FDA, the minimally invasive procedure involves threading a catheter to the kidneys and using energy to disrupt overactive nerves. 研究表明,平均有8-10点的血压下降,使得一些病人能够减少药物治疗。 Studies show an average 8-10 point drop in blood pressure, allowing some patients to reduce medication. 然而,它不适合于所有人, 长期影响仍然未知。 However, it's not suitable for all, and long-term effects are still unknown.